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Abstract
Background: Activation induced deaminase (AID) mediates class switch recombination and somatic hypermutation of
immunoglobulin (Ig) genes in germinal centre B cells. In order to regulate its specific activity and as a means to keep off-
target mutations low, several mechanisms have evolved, including binding to specific cofactors, phosphorylation and
destabilization of nuclear AID protein. Although ubiquitination at lysine residues of AID is recognized as an essential step in
initiating degradation of nuclear AID, any functional relevance of lysine modifications has remained elusive.
Methodology/Principal Findings: Here, we report functional implications of lysine modifications of the human AID protein
by generating a panel of lysine to arginine mutants of AID and assessment of their catalytic class switch activity. We found
that only mutation of Lys22 to Arg resulted in a significant reduction of class switching to IgG1 in transfected primary
mouse B cells. This decrease in activity was neither reflected in reduced hypermutation of Ig genes in AID-mutant
transfected DT40 B cell lines nor recapitulated in bacterial deamination assays, pointing to involvement of post-translational
modification of Lys22 for AID activity in B cells.
Conclusions/Significance: Our results imply that lysine modification may represent a novel level of AID regulation and that
Lys22 is important for effective AID activity.
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Introduction
Activation induced deaminase (AID) induces class switch
recombination (CSR) and somatic hypermutation (SHM) of Ig
genes in B cells during the germinal centre reaction [1,2,3]. CSR
changes the constant region of the antibody, thereby changing its
effector function, whereas SHM increases the affinity of the
antibody towards specific antigen by mutating the variable domain
followed by selection of high affinity variants. AID initiates both
processes by deaminating cytosines within the Ig genomic DNA,
thereby generating uracils, which lead to DNA mismatches
[4,5,6]. These mismatches are either processed into dsDNA
breaks for CSR, or into mutations for SHM [7,8].
Since AID is a DNA-mutating enzyme, its activity has to be
tightly controlled to avoid collateral damage. Although AID is
primarily targeted to the Ig locus for exerting its mutating
function, leakiness of this process is evidenced by AID- mediated
off-target mutations in non-Ig genes, including a panel of proto-
oncogenes like c-myc, Bcl6 and p53 [9,10]. In addition, as a result of
mistargeted CSR, AID also contributes to the translocation of
proto-oncogenes into the Ig locus, thereby accelerating malignant
transformation and tumorigenesis [11,12]. To ensure that AID-
activity is largely restricted to the Ig locus, AID is regulated on
different levels including (i) transcription [13,14,15], (ii) phosphor-
ylation of residues T27, S38, Y184 and T140 [16,17,18], (iii) by
binding of partner proteins to AID (reviewed in [8], (iv) by protein
stability and (v) by subcellular localization [19,20,21].
Though AID acts on genomic DNA, it is largely restricted to the
cytoplasm due to a strong C-terminal Exportin/Crm1-dependent
nuclear export sequence (NES), which can be blocked by
leptomycin B (LMB) [22,23,24]. Deletion or mutation of the
NES leads to nuclear accumulation of AID, based on active
import, which is mostly dependent on the structural integrity of
AID and independent of a defined nuclear localization sequence
(NLS) [21]. Interestingly, while deletion of the NES leads to
nuclear accumulation and an increased mutational activity at Ig-
as well as non-Ig genes, the CSR-activity of AID is strongly
impaired [25]. Additionally, nuclear accumulation is accompanied
by degradative ubiquitination and decreased protein stability
[20,19]. Based on these findings, it is supposed that AID is
restricted to the cytoplasm to minimize the level of off-target
mutations and to allow the production of stable AID protein,
which is necessary for CSR.
Although it could be previously shown that lysine residues
within the AID protein are ubiquitinated when nuclear export is
blocked, functional implications of lysine modifications have not
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modification of lysine residues within the AID protein is important
for CSR and SHM activity. Using a lysine to arginine mutagenesis
screen, we found that mutating Lys22 to Arg (termed mutant K3)
hampers CSR activity in B cells. However, despite of reduced
activity in CSR, mutant K3 was active to wildtype levels in somatic
hypermutaion and in bacterial deamination assays. Our experi-
ments suggest a role of Lys22 in potentiating CSR activity of AID,
providing evidence for a novel level of AID regulation.
Results
CSR activity of AID lysine to arginine mutants
As depicted in figure 1A, the human AID protein comprises
eight lysine residues. To dissect the involvement of lysine
modification in AID activity, we performed a mutational analysis
by generating individual lysine to arginine mutants (K1 to K8,
Fig. 1A) and tested the resulting mutants in class switch assays.
Therefore, we retrovirally transfected primary AID deficient B
cells with the respective AID mutants (K1 to K8) and determined
class switching to IgG1 upon stimulation with LPS and IL-4.
Interestingly, only mutation of lysine at position 22 (mutant K3)
showed an apparent effect on CSR activity (Fig. 1B, C and D),
which prompted us to more thoroughly investigate the influence of
this residue on CSR in higher sample numbers. We could show
that mutating Lys22 significantly affected CSR activity, leading to
a decrease from 14.3% for AID, to 10.0% for K3 of IgG1 switched
B cells (two-tailed paired t-test, p=0.0001, n=11, Fig. 1B and D).
Enzymatic activity of mutant K3 is not perturbed
As mutant K3 showed a decrease in CSR activity, we next asked
whether this decrease is reflected in impaired biochemical activity
of the mutant per se, irrespective of a putative lysine modification
at this position. We therefore tested mutant K3 and wildtype AID
for cytidine deaminase activity in ung deficient E.coli cells,
determined by reversion of an inactive Rif resistance gene [4].
We found a similar frequency of Rif
r colonies in E.coli cells
expressing K3 mutant as opposed to wildtype AID, showing that
mutant K3 is catalytically active at a similar level as wildtype AID
(Fig. 2). However, lysineless AID mutant in which all eight lysine
residues are mutated to arginine (mutant deltaK) has lost
enzymatic activity, probably due to structural destabilization
(Fig. 2).
Mutating Lys22 does not impair nuclear import
Because Lys22 is located within a region of the AID protein
previously found to be responsible for nuclear import [21,23], we
assessed whether mutation of Lys22 to Arg would interfere with
nuclear/cytoplasmic shuttling of AID, which we speculated to be
causative for the observed decrease in CSR activity. We found that
in steady-state conditions, GFP-fusions of AID and mutant K3
were strictly localized to the cytoplasm of transfected B (mouse B
cell line k46) and non-B cells (HEK293T) (Fig. 3). Nuclear
accumulation of GFP-tagged AID and K3 could be induced by
inhibition of nuclear export using LMB, indicating that nuclear
import of AID is not impaired by Lys22Arg mutations (Fig. 3).
Mutant K3 is active in hypermutation
To determine the mutational activity of K3 in eukaryotic cells,
we tested its ability to hypermutate an immunoglobulin V region
gene in the B cell line DT40. Therefore, we transfected AID
2/2
YV
2/2 IgM
+ DT40 cells with AID and K3 constructs,
respectively and determined V region diversification by measuring
the number of IgM-loss variants in several independent clones. We
found similar activity in SHM from K3 transfected cells compared
to those expressing wildtype AID (10.6% vs 8.7% mean IgM-loss;
9.3% vs 5.4% median IgM-loss; p=0.34, unpaired two-tailed
t-test; Fig. 4A). Also, protein levels were similar for wildtype and
mutant K3 (Fig. 4C). To more thoroughly determine the
mutational activity of K3, we sorted for AID or K3 expressing
DT40 variants and analyzed the mutations within the V-region.
We found that the amount of mutations within the V-region was
similar for AID (3 out of 21 sequences mutated) and K3 (5 out of
24 sequences mutated) expressing DT40 cells, with no apparent
difference in hotspot preference being observed (Mutation
frequency 4.1 vs 5.9610
24; p=0.58, unpaired two-tailed t-test;
Fig. 4B and S1). To test off-target activity of AID versus K3, we
analysed mutations within the intronic region of Bcl6, which is
known to be subjected to SHM in germinal centre B cells and
germinal centre derived B cell lymphoma [26,27] and which was
shown to accumulate AID dependent mutations also in mice [28].
Therefore, we retrovirally transfected primary AID deficient
murine B cells with constructs encoding AID or K3 and sequenced
a 600 bp fragment of the intronic Bcl6 locus from GFP
+ sorted
cells. Strikingly, we found mutations in AID-transduced B cells (2
out of 44 independent sequences contained one mutation),
whereas no mutations could be detected in K3 transduced B cells
(p=0.16, unpaired two-tailed t-test; Fig. 4D, S2). From these
results we conclude that Lys22 of AID is more important for CSR
than for IgV diversification but might also lead to an increase in
off-target mutations.
Discussion
AID mediates CSR and SHM by deaminating cytidine residues
within the genomic DNA of the Ig locus. To keep off-target
mutations low and to avoid genomic instability, AID has to be
tightly targeted to the Ig locus and its activity regulated by several
mechanisms, including restricted expression, nuclear/cytoplasmic
shuttling, interaction with binding proteins and phosphorylation at
Ser/Thr residues. Phosphorylation at Ser38 was shown to induce
interaction with Replication Protein A, a DNA binding protein
that is thought to mediate access of AID to transcribed DNA
targets [29,17]. Phosphorylation at Thr140 also regulates CSR
and SHM as inhibition of phosphorylation at this residue
decreases the biological activity of AID [18].
In this study, we aimed at assessing the role of lysine
modification on AID activity. In previously published work it
could be shown that nuclear AID is ubiquitinated at any of its
eight lysine residues to initiate degradation. This was interpreted
as means to keep nuclear AID levels low to avoid genomic
instability [19]. However, conjugation of ubiquitin to cellular
proteins not only initiates their destabilization but alternatively can
modulate their specific function or their cellular trafficking
[30,31]. In this respect, we investigated the functional implication
of single lysine to arginine mutants of the human AID protein and
found that Lys22 is important in potentiating the specific activity
of AID. While mutating Lys22 to Arg had no significant effect on
AID activity in E.coli (Fig. 2) and on SHM in DT40 B cells (Fig. 4A,
B, C), the implication on CSR activity was more pronounced,
reflected in a significant reduction of IgG1 switched primary B
cells (Fig. 1). Although Lys22 had no substantial effect on IgV
diversification in DT40, off target Bcl6 mutations were reduced in
B cells expressing K3 compared to wt AID (Fig. 4D), implying that
increased collateral damage might accompany a more efficient
CSR activity.
As lysine-ubiquitination of AID was recently demonstrated to be
involved in regulating AID stability/degradation [19,32], we
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PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30667Figure 1. Effect of lysine to arginine mutations in the AID protein on CSR activity. (A) Schematic representation of AID highlighting the
position of the lysine (K) residues. For CSR assays, untagged constructs were expressed bicistronically together with GFP separated by an internal
ribosome entry site (IRES). (B) Representative FACS profile for CSR activity of individual Lys to Arg mutants. B cells from AID deficient mice were
retrovirally transfected with the respective lysine AID mutant (Mx: empty vector) and CSR to IgG1 was determined upon stimulation of cells with LPS
and IL-4. GFP expression of infected cells was driven from an IRES element located 39 of the stop codon of the cloned AID mutant. The percentage in
the upper right quadrants indicate the percentage of IgG1
+ cells among the GFP
+ (i.e. retrovirally infected) population. (C) Results from three
independent experiments of a screen of lysine mutants showing the percentage of IgG1
+ cells among the GFP
+ population. (D) Results from 11
independent experiments comparing the CSR activity of AID and K3. (E) Western Blot on lysates from B cells retrovirally transfected with the
respective constructs. Black arrowheads indicate specific band. White arrowheads indicate nonspecific band. (IB: immune blot).
doi:10.1371/journal.pone.0030667.g001
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could account for increased CSR activity of wildtype AID
compared to mutant K3. In line with a recent publication, we
found that Lys22 is a potential target of ubiquitin conjugation,
however, ubiquitination is not restricted to a specific lysine residue
as also mutant K3 was found to be ubiquitinated in transfected B
cell lines (data not shown and [19]). In addition, lysine-
independent N-terminal ubiquitination of AID as noticed
especially upon impaired nuclear export [19] makes a clear-cut
analysis of residue-specific ubiquitination difficult. Therefore, it is
difficult to assess whether ubiquitination of Lys22 is actually
responsible for the observed efficacy of wt AID compared to
mutant K3 or whether other explanations account for the
decreased effectiveness of mutant K3. In this regard it is
conceivable that Lys22 is modified by other functional groups
such as sumo, acetyl or methyl groups, or otherwise, that Lys22
has an intrinsic effect on CSR activity of AID. In either case,
Lys22 could either affect targeting of AID to S-regions or the
assembly of AID into a putative multiprotein-complex which
executes CSR. In this regard it will be interesting not only to test
for the presence of post-translational Lys22 modifications but also
to analyze whether Lys22 mutation affects interaction with
recently identified AID-interacting proteins such as CTNNBL1
[33], PKA [29], Spt5 [34], GANP [35], PTBP2 [36] and 14-3-3
adaptor proteins [37] which were found to recruit AID to its DNA
target sites.
Notably, Lys22 is highly conserved as it can be found in AID
from mammals and birds whereas AID from frog, bony- and
pufferfish share an Arg residue at this position (Fig. S3). While
SHM is present already in cartilaginous fish and is likely to occur
in all jawed vertebrates, CSR appeared late in evolution and can
be found only in land vertebrates, starting with amphibians [38].
Together with our observation that mutant K3 has more dramatic
effects on CSR than SHM, this raises the possibility that Lys22
had co-evolved with the mechanism of CSR.
AID is regulated at several levels, including transcription,
nuclear/cytoplasmic shuttling and phosphorylation. Our notion
that Lys22 is important for proper AID function introduces lysine
modification as a novel level of AID regulation. Future work will
be required to unravel the role of Lys22 in mediating interactions
with AID-binding proteins and to identify the presence of any
functional lysine modifications at this position, such as sumoyla-
tion, methylation or acetylation.
Materials and Methods
Ethics statement
No ethics statement is required: the research described in this
manuscript does not involve human participants. Also, no
experimental procedures were performed on live animals. Mice
used for this research were maintained at the animal facility of the
University of Salzburg according to the national guidelines for
animal welfare. Mice were killed by CO2 suffocation and spleens
were used for further experiments.
Figure 2. Mutational activity of Lys22 mutants. Rifampicin (Rif)
resistance assay for AID-mediated cytidine deamination in UNG-
deficient BW310 E.coli. The graph shows the mutation frequency
(defined as the frequency of Rif-resistant clones) of individual starting
colonies from E.coli transfected with the empty vector or plasmids
expressing wt AID, K3 or lysineless deltaK. Median values 6 SD are
indicated in the graph.
doi:10.1371/journal.pone.0030667.g002
Figure 3. Subcellular localization of K3 is not different from
wildtype AID. (A) Schematic representation of AID-GFP fusion
constructs used for localization assays. GFP is fused to the C-terminus
of AID or mutant K3. (B) HEK293T cells were transiently transfected with
the respective GFP-fusion constructs. Two days post transfection, cells
were treated as indicated with Leptomycin B (LMB) for 3 hours. Cells
were fixed and localization of the respective GFP fusion proteins
visualized using fluorescence microscopy. (C) The k46 B cell line stably
expressing AID-GFP or K3-GFP fusion proteins were treated with or
without Leptomycin B (LMB) for 3 hours and localization of GFP fusion
constructs was determined using fluorescence microscopy.
doi:10.1371/journal.pone.0030667.g003
The Role of Lysines in Regulating AID Activity
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e30667Class Switch assay
Class switching was analysed as previously described [20].
Briefly, B cells were purified from AID
2/2 mice [3] and cultured
in the presence of LPS and IL-4 for one day prior to infection with
human AID (or variants) encoding retroviruses. CSR to IgG1 was
analysed by flow cytometry three days after retroviral infection.
For retrovirus production, Plat-E [39] cells were transfected with
pMx-Ig-derived plasmids using Genejuice (Novagen). Lysine
mutants of human AID were cloned into pMx-Ig plasmids using
BamHI/XhoI sites and site-directed mutagenesis.
Somatic Mutation
AID-induced IgV gene somatic mutation was monitored by
measuring the frequency of sIgM-loss variants in AID
2/2 YV
2/2
sIgM
+ DT40 cells [40] transfected with hAID-encoding vectors
based on pExpressPuro2 (gift from J-M Buerstedde, Munich,
Germany). Independent stable transfectants were expanded for 4
weeks and analysed by flow cytometry for the percentage of cells
retaining surface IgM expression. For analysis of mutations in the
IgV, genomic DNA was prepared from GFP+ sorted cells and
DNA was amplified using specific primers (V-fwd: 59-GGT GCA
GGC AGC GCT GAC TCA GCC GGC CTC-39; V-rev: 59-
CCA AAT CAC CAA AAA TCG ACA AAA TGT CAC-39), and
cloned using TOPO-cloning (invitrogen) followed by sequencing
of independent clones.
Off-target mutations within the Bcl6 intronic region were
determined from primary retrovirally transfected mouse B cells.
Briefly, primary resting B cells from AID deficient mice were
retrovirally transfected with AID or K3 encoding constructs as
described for CSR-assays. Transfected cells were sorted 3 days
after transfection using FACS-sorting based on GFP expression
and genomic DNA was isolated. PCR amplification of intronic
Bcl6 region was achieved using specific primers as described by
Muto et al [28] (59-CTT TCT TGG TTG GAG TCG AGG C-
39;5 9-CGG GCT TGA GGT CAT TTC TC-39) followed by
TOPO-cloning of purified PCR fragments and sequencing of
several independent clones.
AID-induced mutations in E.coli
Bacterial assays were performed essentially as described in Petersen-
Mahrt et al. [4]. In brief, AID-induced mutations were monitored by
measuring the frequency of Rifampicin (Rif) resistant clones that are
generated by mutation of a Rif-sensitive allele in an Uracil-DNA
Glycosylase (UNG)-deficient BW310 E.coli strain. Individual clones of
BW310 cells transfected with empty vector or AID or K3
(AID
Lys22Arg) expressing pTrc99 [4] based constructs were grown
over night in 3 ml IPTG-containing medium at 30uC. Cultures were
then spread on Rif and Ampicillin plates and the appearance of Rif-
resistant clones was calculated (Mutation frequency).
AID Localization
Constructs encoding AID or AID-variants fused C-terminally to
GFP were generated by PCR-based mutagenesis and cloned into
pEGFP-N1 (Clontech). The respective contructs were transiently
Figure 4. Somatic Hypermutation of IgV genes by wt AID and mutant K3. (A) Somatic hypermutation reflected as loss of IgM expression in
AID
2/2 YV
2/2 IgM
+ DT40 cells. AID
2/2 YV
2/2 IgM
+ DT40 cells were stably transfected with plasmids encoding AID or K3 coupled to IRES-GFP
expression. The percentage of sIgM-loss variants of GFP
+ cells is expressed as the median 6 SE of multiple (n) independent clonal transfectants
determined three weeks after transfection (untransfected control, n=12; AID, n=36; K3, n=44). (B) Proportion of sequences carrying mutations in IgV
genes of DT40 cells. IgV regions were cloned from cDNA of AID and K3 expressing DT40 transfectants. Segment sizes in the pie charts are
proportional to the number of sequences carrying the number of mutations indicated in the periphery of each chart. The frequency of mutations per
bp sequenced and the total number of independent sequences analyzed is indicated underneath and in the center of each chart, respectively. (C) The
abundance of AID and K3 in DT40 transfectants was determined by Western blotting from cell extracts. Blots were reprobed for GFP expression and
actin levels as loading control. (D) Proportion of sequences carrying Bcl6 mutations in AID deficient B cells retrovirally transfected with AID or K3
constructs, respectively. Bcl6 was cloned from genomic DNA of sorted mouse B cells, retrovirally transfected to express AID or K3, respectively. Pie
charts were generated as described in (B).
doi:10.1371/journal.pone.0030667.g004
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Genejuice and replated onto glass slides 24 h after transfection.
Alternatively, stable transfectants of the mouse B cell line k46 [42],
expressing pEGFP-N1 based AID-GFP fusion constructs were
used. Nuclear export of AID was blocked by incubation of cells
with Leptomycin B at a final concentration of 10 ng/ml for 3 h.
Cells were fixed in 4% paraformaldehyde, permeabilized with
0.5% Triton X-100 and cell nuclei were stained using 1 mg/ml
DAPI and covered in mounting medium (Vectashield).
Western Blotting
Approximately 10e6 retrovirally transfected B cells or 10e5
DT40 cells were boiled in 50 ml of reducing SDS-sample buffer
and subjected to SDS/PAGE. Samples were blotted onto PVDF
membranes (Millipore) and detected by Western blot analysis
using polyclonal rabbit serum specific for human AID (Abcam),
GFP (Cell Signaling), or actin (Cell Signaling) and HRP-
conjugated secondary antibodies specific for rabbit IgG (Dako).
Supporting Information
Figure S1 Mutations identified within the IgV gene from
DT40 cells transfected with AID or K3, respectively. The
depicted sequence of the IgV gene was PCR amplified from
transfected DT40 cells. Primer binding sites are underlined.
Independent mutations are shown in uppercase letters above
(AID; n=21) and below (K3; n=24) the IgV sequence,
respectively. Mutations at hotspots (RGYW or WRCY motifs
according to Rogozin and Kolchanov, 1992) are indicated as bold
consensus sequence.
(DOC)
Figure S2 Mutations identified within the bcl6 gene
from primary mouse B cells retrovirally transfected
with AID or K3, respectively. The depicted sequence of the
bcl6 intronic region was PCR amplified from retrovirally
transfected and sorted mouse B cells. Independent mutations for
AID (n=44) are shown in uppercase letters above the bcl6 intronic
sequence. No mutations were found for K3 (n=49). (Accession
No# NT_039624.7).
(DOC)
Figure S3 Lys22 is conserved in higher vertebrates and
birds. Alignment of AID protein sequences from various species
showing that Lys22 is conserved in birds and mammals. Species
competent for switching are marked in bold. Sequences derived
from M. Chatterji et al, J. Immunol. 2007;179;5274–5280.
(DOC)
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